Form 4: Neuronetics Director Transfers Shares to Madryn Funds

Director Avinash Amin transferred shares of Neuronetics, Inc. common stock to affiliated Madryn Health Partners funds as part of director compensation.

Summary

• Director Avinash Amin transferred a total of 40,500 shares of Neuronetics, Inc. common stock.
• These shares were transferred to three different Madryn Health Partners funds: Madryn Health Partners II, LP, Madryn Health Partners II (Cayman Master), LP, and Madryn Select Opportunities, LP.
• The transfers were made as part of director compensation and were without consideration.
• Following these transfers, Avinash Amin beneficially owns 30,000 shares of common stock directly.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as having a low sentiment score as it is purely a transactional disclosure without any performance or strategic information, offering limited insight into the company's operational health.

Positives

• Director compensation structure is in place, facilitating the transfer of shares.
• Clear reporting of share transfers to affiliated entities.

Negatives

• The filing does not provide financial performance data or strategic updates, making it difficult to assess the company's overall health.
• The nature of the transfers, while part of compensation, represents a movement of shares rather than an acquisition of new value by the director.

Risks

• The filing does not contain information on specific risks or challenges faced by Neuronetics, Inc.

Future Outlook

No forward-looking statements or guidance are provided in this filing.

Industry Context

StockSavvy.ai notes that Form 4 filings typically report changes in beneficial ownership by insiders, such as directors and officers. These filings are crucial for understanding insider activity but do not inherently provide company performance or strategic insights.

Related Party Transactions

• Transfer of shares from director Avinash Amin to Madryn Health Partners II, LP, Madryn Health Partners II (Cayman Master), LP, and Madryn Select Opportunities, LP, as part of director compensation.

Stakeholder Impact

• Shareholders: The transfer of shares among affiliated entities does not directly impact the total number of outstanding shares but reflects a change in beneficial ownership structure.
• Management/Directors: The filing details a component of director compensation and the subsequent allocation of those shares.

Next Steps

• No specific next steps are mentioned in the filing.

Key Dates

Keywords

Neuronetics, STIM, Form 4, Insider Trading, Director Compensation, Share Transfer, Madryn Health Partners